TechnologyFriday 05.26.23

Elon Musk’s Neuralink said it has FDA approval to conduct the first clinical trial of its experimental device in humans.

Want to show your appreciation for The Recount's coverage?
Tip us!Tip us!

Recount Wire

ADVERTISEMENT